+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Antibiotic Resistance Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies & Beta-Lactamase Inhibitors), By Target Pathogen (Escherichia coli (E. coli), Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus (MRSA), Acinetobacter baumannii, Streptococcus pneumoniae, Clostridioides difficile (C. difficile), Enterococcus faecium (VRE)), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA , Folic-Acid Pathway Inhibitors), By Disease Indication (Complicated Urinary Tract Infections (cUTI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired , Clostridioides difficile Infection (CDI), Complicated Intra-Abdominal Infections (cIAI), Bloodstream Infections (BSI) ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Antibiotic Resistance Market size is forecast to increase from $11.68 Billion in 2026 to $17.66 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005627
Pages: 227 Pages

Anti-biofilm Wound Dressing Market Size, Share and Growth Outlook, 2026: Analysis By Mode of Mechanism (Chemical Mechanism, Physical Mechanism, Biological Mechanism), By Dressing Material (Alginate Dressings, Foam Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Film and Membrane Dressings, Nanofiber & Bacterial Cellulose Dressings), By Active Antimicrobial Agent (Silver-Based Agents, Iodine-Based Agents, Polyhexanide (PHMB), Honey & Natural Bio-actives, Chitosan & Biopolymers), By Wound Type (Chronic Wounds , Acute Wounds ), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), Home Healthcare Settings, Military and Emergency Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Anti-biofilm Wound Dressing Market size is forecast to increase from $1079.45 Million in 2026 to $2280.45 Million in 2034 at a CAGR of 9.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005626
Pages: 217 Pages

Antibacterial Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Penicillins, Cephalosporins, Carbapenems & Monobactams, Macrolides, Fluoroquinolones, Aminoglycosides, Sulfonamides & Tetracyclines, Glycopeptides, Lipopeptides, & Oxazolidinones), By Mechanism of Action (Cell-Wall Synthesis Inhibitors, Protein-Synthesis Inhibitors, DNA , Folic-Acid Pathway Inhibitors, Membrane Disruptors), By Spectrum of Activity (Broad-Spectrum Antibacterials, Narrow-Spectrum Antibacterials), By Route of Administration (Oral, Parenteral (Intravenous , Topical ), By Application (Respiratory Tract Infections, Urinary Tract Infections (UTIs), Skin and Soft Tissue Infections, Gastrointestinal Infections, Bloodstream Infections ), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Antibacterial Drugs Market size is forecast to increase from $47.02 Billion in 2026 to $61.44 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005625
Pages: 230 Pages

Antiarrhythmic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Sodium Channel Blockers (Class I), Beta Blockers (Class II), Potassium Channel Blockers (Class III), Calcium Channel Blockers (Class IV), Miscellaneous ), By Disease (Supraventricular Arrhythmias, Ventricular Arrhythmias), By Route of Administration (Oral Formulations, Injectable ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Antiarrhythmic Drugs Market size is forecast to increase from $1.38 Billion in 2026 to $2.27 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005624
Pages: 218 Pages

Anti-aging Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Ingredient Type (Vitamins , Minerals , Proteins & Peptides , Herbal & Botanical Extracts , Omega-3 Fatty Acids, Probiotics & Postbiotics, Coenzyme Q10 ), By Product Form (Tablets & Capsules, Powders, Liquid/Syrups, Gummies & Soft Chews), By Application (Skin, Hair & Nail Health , Cognitive & Brain Health, Joint & Bone Health, Cellular Vitality & Energy Metabolism, Immune Support), By Distribution Channel (Hypermarkets & Supermarkets, Specialty Nutrition Stores, Pharmacies & Drug Stores, Online/E-commerce Platforms) Companies, and Country Forecast, 2021 to 2034

Global Anti-aging Supplements Market size is forecast to increase from $4.66 Billion in 2026 to $9.02 Billion in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005623
Pages: 224 Pages

Anti-aging Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Non-Invasive Aesthetic Procedures , Minimally Invasive Aesthetic Procedures , Invasive/Surgical Procedures , Regenerative Medicine Services , Hormone Replacement Therapy , Longevity & Wellness Programs ), By Demographics (Generation Y , Generation X, Baby Boomers), By End User (Dermatology Clinics, Medical Spas & Aesthetic Centers, Hospitals & Specialty Healthcare Facilities, Wellness & Longevity Retreats) Companies, and Country Forecast, 2021 to 2034

Global Anti-aging Services Market size is forecast to increase from $22.9 Billion in 2026 to $35.41 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005622
Pages: 218 Pages

Anti-aging Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Hormonal Therapy , Antioxidants & Enzymes, Stem Cell Therapy, Senolytic Drugs, NAD+ Boosters & Metabolic Regulators, Retinoids & Topically Applied Pharmaceutical Actives), By Route of Administration (Oral, Injectable/Parenteral, Topical), By Indication (Skin and Hair Rejuvenation, Skeletal and Muscle Health , Age-related Degenerative Disorders , Metabolic Health), By Distribution Channel (Hospital Pharmacies, Specialty Clinics & Longevity Centers, Retail Pharmacies, Online/E-commerce Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anti-aging Drugs Market size is forecast to increase from $68.85 Billion in 2026 to $153.04 Billion in 2034 at a CAGR of 10.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005621
Pages: 220 Pages

Anti-acne Dermal Patch Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Hydrocolloid Patches, Microneedle Patches, Hydrogel Patches, Silicone Patches), By Ingredient Type (Chemical-Based , Herbal/Natural-Based , Non-Medicated/Active-Free ), By Acne Type (Inflammatory Acne , Non-Inflammatory Acne ), By Distribution Channel (Pharmacies and Drug Stores, E-Commerce Platforms, Retail Beauty Stores, Supermarkets and Specialty Stores), By End User (Individual Consumers, Dermatology Clinics and Medical Spas) Companies, and Country Forecast, 2021 to 2034

Global Anti-acne Dermal Patch Market size is forecast to increase from $687.11 Million in 2026 to $1137.16 Million in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005620
Pages: 210 Pages

Anti-acne Cosmetics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Cleansers and Toners, Creams and Lotions, Masks and Peels, Emulsions and Gels, Spot Treatments), By Formulation (Chemical-Based , Herbal/Natural-Based ), By End User (Women, Men), By Distribution Channel (Offline , Online) Companies, and Country Forecast, 2021 to 2034

Global Anti-acne Cosmetics Market size is forecast to increase from $6.08 Billion in 2026 to $11.94 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005619
Pages: 225 Pages

Anthrax Vaccine Market Size, Share and Growth Outlook, 2026: Analysis By Vaccine Type (Cell-Free Anthrax Vaccine Adsorbed (AVA), Adjuvanted Anthrax Vaccine, Recombinant Protective Antigen (rPA) Vaccines, Live Attenuated ), By Application Category (Human Use, Veterinary Use), By Application Type (Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP)), By Target End-User (Military & Defense Forces, Government Civilian Agencies & Emergency Stockpiles, Healthcare Workers & First Responders, Veterinary Sector & Livestock Facilities), By Distribution Channel (Direct Government Procurement , Hospital and Clinic Pharmacies, Specialty Veterinary Distributors) Companies, and Country Forecast, 2021 to 2034

Global Anthrax Vaccine Market size is forecast to increase from $15.8 Billion in 2026 to $22.82 Billion in 2034 at a CAGR of 4.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005618
Pages: 227 Pages